Touchlight

Touchlight is a privately-owned Contract Development and Manufacturing Organization (CDMO) based in London, UK, specializing in the enzymatic production of DNA. They have developed a unique synthetic DNA vector called doggybone DNA (dbDNA™) that is designed to be safer and more effective than conventional plasmid DNA. Their enzymatic manufacturing process offers several advantages over traditional methods, including faster production times, scalability, and the elimination of antibiotic resistance genes.

Touchlight's technology is being used to enable the development of a wide range of genetic medicines, including mRNA and DNA vaccines, viral and non-viral gene therapies, and cell therapies. They work with a diverse range of clients, from large pharmaceutical companies to smaller biotechnology startups. Touchlight is committed to innovation and has a strong focus on building a diverse and inclusive workforce. They are also actively involved in supporting the development of new and emerging technologies in the field of genetic medicine.

Touchlight offers employees flexible working arrangements, allowing them to tailor their work schedules to their personal needs. The company's commitment to flexibility is reflected in their job postings, which explicitly mention the provision of flexible working options. Although specific details about the types of flexibility offered are not provided, it appears that employees have the opportunity to adjust their work hours and potentially work remotely.

Touchlight offers a competitive benefits and remuneration package to its employees, including incredible facilities, flexible working arrangements, and a welcoming, entrepreneurial culture. The company believes in fostering a dynamic work environment where employees can thrive and contribute to its mission of revolutionizing the field of genetic medicine.

Touchlight is a biotechnology company dedicated to powering the genetic medicine revolution by making DNA faster, safer, and more efficiently than traditional methods. They have developed a unique enzymatic DNA production platform, known as doggybone DNA, which eliminates bacterial sequences, enables the production of long and complex sequences, and allows for rapid, scalable manufacturing with a smaller footprint than traditional fermentation-based methods. Their mission is to provide this technology as a service to their partners in the genetic medicine industry, enabling the development and commercialization of the next generation of DNA-based therapies and vaccines.

Touchlight fosters a vibrant and collaborative culture that values innovation, excellence, and people. They prioritize attracting, employing, and retaining highly talented individuals, celebrating creativity and diversity. The company offers a dynamic and enjoyable work environment in state-of-the-art facilities, promoting internal training and development opportunities, flexible working, and a competitive benefits package.

Touchlight believes that diversity drives innovation and fosters a welcoming, entrepreneurial culture that attracts and retains highly talented individuals from all backgrounds. They are committed to finding, employing, and retaining employees who are diverse in gender, ethnicity, and physical ability. Touchlight ensures equal opportunities for all employees and has designed its Hampton site to be accessible to all. They provide internal training programs and access to professional development opportunities, as well as competitive salaries and incentives to recognize success and contribution.